GMTX
Gemini Therapeutics Inc
$1.35
Earnings Summary
Revenue | $0Mn |
Net Profits | $-3.28Mn |
Net Profit Margins | -Inf% |
Highlights
Gemini Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2022. On a quarterly growth basis, Gemini Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.
Gemini Therapeutics Inc’s net profit jumped 82.34% since last year same period to $-3.28Mn in the Q3 2022. On a quarterly growth basis, Gemini Therapeutics Inc has generated 53.78% jump in its net profits since last 3-months.
Gemini Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2022. On a quarterly growth basis, Gemini Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Gemini Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.12 |
EPS Estimate Current Year | -0.12 |
Highlights
Gemini Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.12 - a -33.33% fall from last quarter’s estimates.
Gemini Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.12.
Key Ratios
Key ratios of the Gemini Therapeutics Inc post its Q3 2022 earnings
Earning Per Share (EPS) | -0.08 |
Highlights
Gemini Therapeutics Inc’s earning per share (EPS) jumped 81.4% since last year same period to -0.08 in the Q3 2022. This indicates that the Gemini Therapeutics Inc has generated 81.4% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2022-05-06 | -0.3 | -0.35 | -16.67% |
2022-11-10 | -0.09 | -0.08 | 11.11% |
2022-08-11 | -0.2 | -0.16 | 20% |
₹0 US Stocks a/c Opening Fee